JK
Jayadeva Kangila
About Jayadeva Kangila
Data last updated:
Jayadeva Kangila is a Director at Carewell Hospitals And Research Centre Pvt Ltd (since 2005) and Director at Vcarewell Super Speciality Hospital Private Limited (since 2025). The companies operate in Healthcare. The largest current company by reported revenue is Carewell Hospitals And Research Centre Pvt Ltd at ₹19.81 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Mar 2005 | 1990 | ₹19.81 Cr (FY 2024) | Active | |
| Director | 22 Jul 2025 | 2025 | Active |
Board colleagues of Jayadeva Kangila
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayadeva Kangila
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayadeva Kangila
Jayadeva Kangila currently holds 2 directorships: Carewell Hospitals And Research Centre Pvt Ltd (Director, since 09 Mar 2005, revenue ₹19.81 Cr (FY 2024)); Vcarewell Super Speciality Hospital Private Limited (Director, since 22 Jul 2025).
Jayadeva Kangila was first appointed on 09 Mar 2005 as Director at Carewell Hospitals And Research Centre Pvt Ltd. The most recent appointment on record is 22 Jul 2025 at Vcarewell Super Speciality Hospital Private Limited.
The current boards of Jayadeva Kangila's companies include Chemnadpudiyapure Mohammed Riyaz (Carewell Hospitals And Research Centre Pvt Ltd), Chethanadka Nagaraja (Carewell Hospitals And Research Centre Pvt Ltd), Fathimath Thahira Ali (Carewell Hospitals And Research Centre Pvt Ltd), Hameed Beefathuma Zuhara (Carewell Hospitals And Research Centre Pvt Ltd), Mogral Arimala Abdulhafeez (Carewell Hospitals And Research Centre Pvt Ltd), Mogral Arimala Aysha Nazeera (Carewell Hospitals And Research Centre Pvt Ltd), among others.